BiocSol secures €4.4M to advance sustainable crop protection
BiocSol, a spin-off from UCLouvain specialising in sustainable crop protection, has raised an additional €4.4 million ($4.58 million) in funding. The latest investment includes an equity contribution from Dutch impact investment fund Pymwymic and non-dilutive financing from the Walloon Region through the Win4company programme. This funding brings BiocSol closer to its €10 million target, aimed at accelerating its development and commercialisation efforts.
This round follows a €5.2 million ($5.4 million) equity investment secured in November 2024, led by Agri Investment Fund and VIVES Partners. The newly acquired funds will primarily support the expansion of BiocSol’s R&D platform. The funds will also facilitate the global proof-of-concept demonstration for its first 2 biofungicide products.
€10 million goal
“With this financing, we are on track to achieve our €10 million goal, which will enable us to fast-track development. This investment reaffirms our commitment to providing farmers with effective and sustainable biosolutions,” said Denis Payen, CEO of BiocSol. “We are delighted to welcome Pymwymic as an investor. Their support will bolster our growth and help us integrate impact-driven strategies into our daily operations. With our new chairman of the board, Pierre Ferrand, and a dedicated team, we are well-positioned for the next phase of BiocSol’s journey.”
Backing of Walloon Region
BiocSol has also acknowledged the continued backing of the Walloon Region, which has supported the start-up since its inception. Additionally, the company credits the Laboratory of Plant Pathology (SAVE) under the leadership of Anne Legrève and Claude Bragard. It also credits the Laboratory of Food and Environmental Microbiology (MIAE) led by Jacques Mahillon and Annika Gillis at UCLouvain, for their crucial role in BiocSol’s development.
Pymwymic partner Pieter Vis emphasised the significance of BiocSol’s innovation in the agricultural sector. “With a strong biosolution pipeline and expertise in developing microbial substances for various crops, BiocSol has the potential to provide farmers with viable, cost-effective alternatives to traditional crop protection methods,” he said. “We are proud to support a company with such promise, a respected group of co-investors, and a highly skilled team led by Denis Payen and Simon Caulier.”
